Domov › Akútna biphenotypová leukémia › Texas

Klinické štúdie Akútna biphenotypová leukémia v štáte Texas

13 štúdií pre Akútna biphenotypová leukémia hľadá účastníkov v zariadeniach v štáte Texas.

Mestá v štáte Texas

Oficiálny text štúdie (anglicky)

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

University of Texas MD Anderson Cancer Center, Houston

Prebieha náborFáza 1

Vek 12 až 78 · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT03802695

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Dell Children's Medical Center of Central Texas, Austin
Driscoll Children's Hospital, Corpus Christi
Medical City Dallas Hospital, Dallas
a 7 ďalších

Prebieha náborFáza 2

365 Days · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06317662

Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation

M D Anderson Cancer Center, Houston

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT03683433

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Dell Children's Medical Center of Central Texas, Austin
Driscoll Children's Hospital, Corpus Christi
Medical City Dallas Hospital, Dallas
a 12 ďalších

Prebieha náborFáza 3

365 Days – 25 Years · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Dell Children's Medical Center of Central Texas, Austin
Driscoll Children's Hospital, Corpus Christi
Medical City Dallas Hospital, Dallas
a 10 ďalších

Prebieha náborFáza 1/2

Do veku 22 · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT04726241

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

University of Texas MD Anderson Cancer Center, Houston

Prebieha náborFáza 1/2

Vek 13 až 90 · Všetky pohlavia · Aktualizované 6. 8. 2026 · NCT06533579

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

UT Southwestern/Simmons Cancer Center, Dallas
Cook Children's Medical Center, Fort Worth

Prebieha náborFáza 1

Vek 1 až 30 · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT06177067

Personalized NK Cell Therapy in CBT

M D Anderson Cancer Center, Houston

Prebieha náborFáza 2

Vek 15 až 80 · Všetky pohlavia · Aktualizované 30. 7. 2026 · NCT02727803

A Study of Revumenib and Mezigdomide in People With Leukemia

MD Anderson Cancer Center (Data Collection Only), Houston

Prebieha náborFáza 1/2

Vek 12 a viac · Všetky pohlavia · Aktualizované 22. 6. 2026 · NCT07356154

Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

M D Anderson Cancer Center, Houston

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 12. 6. 2026 · NCT04047641

Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

M D Anderson Cancer Center, Houston

Prebieha náborFáza 2

Vek 18 až 65 · Všetky pohlavia · Aktualizované 20. 5. 2026 · NCT02115295

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

University of Texas(UT) Southwestern-Children's Medical Center, Dallas

Prebieha náborFáza 1/2

Vek 12 až 95 · Všetky pohlavia · Aktualizované 15. 4. 2026 · NCT04329728

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

University of Texas, Southwestern, Dallas
Cook Children's Hospital, Fort Worth
Texas Children's Hospital/Baylor College of Medicine, Houston

Prebieha náborFáza 1

Vek 1 až 21 · Všetky pohlavia · Aktualizované 6. 12. 2024 · NCT05476770

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.